Page last updated: 2024-12-07
beta-ethylstyrene oxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
beta-ethylstyrene oxide: reagent for measurement of cytosolic epoxide hydrolase; RN given refers to cis isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 125747 |
MeSH ID | M0088200 |
Synonyms (14)
Synonym |
---|
ccris 6863 |
trans-2-ethyl-3-phenyloxirane |
cis-2-ethyl-3-phenyloxirane |
oxirane, 2-ethyl-3-phenyl-, cis- |
beta-ethylstyrene oxide |
(2r,3r)-2-ethyl-3-phenyloxirane |
69140-51-8 |
unii-1hqy57944z |
1hqy57944z , |
cis-.beta.-ethylstyrene oxide |
2-ethyl-3-phenyloxirane, cis- |
oxirane, 2-ethyl-3-phenyl-, (2r,3s)-rel- |
Q27252432 |
DTXSID701031859 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.35
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.35) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |